SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-12B/A - Registration of securities [Section 12(b)]: [Amend]
SEC Accession No. 0001104659-13-053548
Filing Date
2013-07-09
Accepted
2013-07-08 21:54:46
Documents
9

Document Format Files

Seq Description Document Type Size
1 10-12B/A a13-11577_11012ba.htm 10-12B/A 2319363
2 EX-10.8 a13-11577_1ex10d8.htm EX-10.8 736172
3 EX-10.12 a13-11577_1ex10d12.htm EX-10.12 692262
4 EX-10.29 a13-11577_1ex10d29.htm EX-10.29 111653
5 EX-10.30 a13-11577_1ex10d30.htm EX-10.30 114272
6 EX-10.31 a13-11577_1ex10d31.htm EX-10.31 87940
7 EX-23.1 a13-11577_1ex23d1.htm EX-23.1 3244
8 GRAPHIC g115771bc01i001.gif GRAPHIC 3728
9 GRAPHIC g115771bc03i001.jpg GRAPHIC 37381
  Complete submission text file 0001104659-13-053548.txt   4122863
Mailing Address 4660 LA JOLLA VILLAGE DRIVE SUITE 500 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE SUITE 500 SAN DIEGO CA 92122 (514) 337-3333
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-12B/A | Act: 34 | File No.: 001-35921 | Film No.: 13958504
SIC: 2834 Pharmaceutical Preparations